#1Clav's Stack
TrendingLooksmaxxing
24+Research Products
>98%Purity Tested
$200+Free Shipping
VerifiedTrusted Supplier
AlwaysCoA Verified
#1Clav's Stack
TrendingLooksmaxxing
24+Research Products
>98%Purity Tested
$200+Free Shipping
VerifiedTrusted Supplier
AlwaysCoA Verified
Back to Guides
advanced9 min readanti aging peptides

Peptide Bioregulators: Research Guide to Short Peptide Biology

Overview of peptide bioregulator theory, Khavinson's research program, and how tetrapeptides like epithalon modulate gene expression.

Research focus
epithalonpeptide bioregulatorsKhavinsongene regulationepigeneticsanti-aging

Peptide Bioregulator Theory

Peptide bioregulators (cytomedines) are short peptides (2–4 amino acids) derived from tissue-specific proteins that regulate gene expression in corresponding tissues. Developed by Vladimir Khavinson's group over 40 years of research, the bioregulator concept proposes that:

  1. Each tissue produces specific regulatory peptides
  2. These peptides decline with age
  3. Supplementing with synthetic equivalents can restore tissue-specific gene expression
  4. Effects are tissue-specific but not species-specific (bovine-derived peptides active in humans)

Key Peptide Bioregulators

PeptideTissue OriginPrimary Research Area
Epithalon (AEDG)Pineal glandTelomere, longevity
ThymalinThymusImmune function
Cortagen (AEDL)Cerebral cortexNeuroprotection
Vilon (LysTrp)ThymusImmune aging
Cardiogen (AEDR)HeartCardiac protection
Livagen (KEDW)LiverHepatoprotection

Mechanism of Gene Regulation

Khavinson proposed that short peptides interact with DNA regulatory sequences (promoters, enhancers) or histone proteins to modulate gene transcription. Key evidence:

  • Di- and tetrapeptides have been shown to bind specific DNA sequences in vitro
  • Conformational DNA changes following peptide binding alter transcription factor access
  • Epithalon specifically increases hTERT promoter activity
  • Effects are self-limiting (physiological, not supraphysiological)

Epigenetic Mechanisms

Recent research suggests peptide bioregulators may work partly via epigenetic mechanisms:

  • DNA methylation changes at CpG sites following peptide treatment
  • Histone acetylation modifications
  • Chromatin remodeling enabling transcription factor binding

This provides a molecular basis for the tissue-specificity and self-limiting nature of bioregulator effects.

Epithalon as Research Model

Epithalon (AEDG) is the most studied of the peptide bioregulators and serves as a model compound for investigating the broader bioregulator hypothesis. Its defined sequence, reproducible effects, and 50mg research vial format make it ideal for laboratory investigation.

Epithalon 50mg from our verified supplier — for laboratory research only.